Primary Record
VS-5584
- In stock
- 8,506 g
- Purity
- 98.1 %
- CAS
- 1246560-33-7
Compound Identifiers & Properties
- CAS
- 1246560-33-7
- PubChem CID
- 46912230
- SMILES
- CC1=NC2=C(N=C(N=C2N1C(C)C)N3CCOCC3)C4=CN=C(N=C4)N
- Canonical SMILES
- Cc1nc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc2n1C(C)C
Names & Synonyms
- VS-5584
- 1246560-33-7
- SB2343
- RefChem:194645
- D01EUD
- D0U3DP
- 5-(9-Isopropyl-8-methyl-2-morpholino-9H-purin-6-yl)pyrimidin-2-amine
- UNII-W71J4X250V
- VS-5584 (SB2343)
- SB-2343
- W71J4X250V
- MFCD25372027
- VS5584
- CHEMBL3393066
- C17H22N8O
- SCHEMBL539098
- QYBGBLQCOOISAR-UHFFFAOYSA-N
- GTPL8382
- orb1301070
- SCHEMBL29376859
- DTXSID10677328
- EX-A288
- VS 5584 [WHO-DD]
- GLXC-90371
- HMS3652B16
- BCP08247
- SB 2343
- VS 5584
- 2797AH
- BDBM50059635
- NSC778810
- NSC800991
- s7016
- ZINC95644685
- 5-(8-methyl-2-morpholin-4-yl-9-propan-2-ylpurin-6-yl)pyrimidin-2-amine
- AKOS024465057
- ACN-029553
- CCG-268087
- CS-1202
- DB12986
- EBC-157243
- NSC-778810
- NSC-800991
- SB-2312
- SB16877
- NCGC00386370-03
- NCGC00386370-06
- 2-Pyrimidinamine, 5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6-yl]-
- AC-33121
- AS-80075
- BC600432
- CID:46912230
- DA-46738
- HY-16585
- VS-5584?
- SID:383547942
- AB0165544
- A3927
- FT-0700143
- NS00073089
- SW220201-1
- VS-5584 (SB-2343)
- J3.369.231E
- A12480
- W-6043
- 5-[9-Isopropyl-8-methyl-2-(morpholin-4-yl)purin-6-yl]pyrimidin-2-amine
- A857790
- C585120
- MTOR/PI3K alpha dual inhibitors (cancer), S*BIO
- 2-Pyrimidinamine, 5-(8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6-yl)-
- 5-[8-Methyl-2-(morpholin-4-yl)-9-(propan-2-yl)-9H-purin-6-yl]pyrimidin-2-amine
- BRD-K98795921-001-01-7
- Q27089164
- 5-(9-isopropyl-8-methyl-2-morpholin-4-yl-9H-purin-6-yl)-pyrimidin-2-ylamine
- Z2235802244
- 5-(8-METHYL-9-(1-METHYLETHYL)-2-(4-MORPHOLINYL)-9H-PURIN-6YL)-2-PYRIMIDINAMINE
- 5-(9-isopropyl-8-methyl-2-morpholino-purin-6-yl)pyrimidin-2-amine
- 9-Isopropyl-8-methyl-2-morpholino-6-(2-aminopyrimidine-5-yl)-9H-purine
- SB-2343|||5-(8-Methyl-2-morpholin-4-yl-9-propan-2-ylpurin-6-yl)pyrimidin-2-amine
- Mammalian target of rapamycin/phosphoinositide 3 kinase alpha dual inhibitors (cancer), S*Bio